Economic evaluation for the US of nab-paclitaxel plus gemcitabine versus FOLFIRINOX versus gemcitabine in the treatment of metastatic pancreas cancer
M Gharaibeh, A McBride, JL Bootman… - Journal of Medical …, 2017 - Taylor & Francis
Background: Nab-paclitaxel plus gemcitabine (NAB-P+ GEM) and FOLFIRINOX have shown
superior efficacy over gemcitabine (GEM) in the treatment of metastatic pancreatic ductal …
superior efficacy over gemcitabine (GEM) in the treatment of metastatic pancreatic ductal …
Economic evaluation for the US of nab-paclitaxel plus gemcitabine versus FOLFIRINOX versus gemcitabine in the treatment of metastatic pancreas cancer.
M Gharaibeh, A McBride, JL Bootman… - Journal of Medical …, 2016 - europepmc.org
Background Nab-paclitaxel plus gemcitabine (NAB-P+ GEM) and FOLFIRINOX have shown
superior efficacy over gemcitabine (GEM) in the treatment of metastatic pancreatic ductal …
superior efficacy over gemcitabine (GEM) in the treatment of metastatic pancreatic ductal …
Economic evaluation for the US of nab-paclitaxel plus gemcitabine versus FOLFIRINOX versus gemcitabine in the treatment of metastatic pancreas cancer
M Gharaibeh, A McBride… - Journal of medical …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Nab-paclitaxel plus gemcitabine (NAB-P+ GEM) and FOLFIRINOX have shown
superior efficacy over gemcitabine (GEM) in the treatment of metastatic pancreatic ductal …
superior efficacy over gemcitabine (GEM) in the treatment of metastatic pancreatic ductal …
[引用][C] Economic evaluation for the US of nab-paclitaxel plus gemcitabine versus FOLFIRINOX versus gemcitabine in the treatment of metastatic pancreas cancer
M Gharaibeh, A McBride, JL Bootman, H Patel… - Journal of Medical …, 2016 - cir.nii.ac.jp
Economic evaluation for the US of nab-paclitaxel plus gemcitabine versus FOLFIRINOX versus
gemcitabine in the treatment of metastatic pancreas cancer | CiNii Research CiNii 国立情報学 …
gemcitabine in the treatment of metastatic pancreas cancer | CiNii Research CiNii 国立情報学 …